Implications of LDHC5 for Muscle-Related Diseases (G3948)

Target Name: LDHC

NCBI ID: G3948

LDHC

Implications of LDHC5 for Muscle-Related Diseases

LDHC (Lactate Dehydrogenase C Variant 5) is a gene that encodes a protein known asLDHC5. It is a member of theLDH gene family, which is responsible for producing the same enzyme found in red blood cells, called lactate dehydrogenase. This enzyme plays a crucial role in the metabolism of glucose and lactate, which are both essential for muscle growth and recovery.

LDHC5 is a variant of theLDH gene, which means that it has a genetic variation in the sequence of its amino acid residues. This genetic variation can result in changes in the structure and function of the enzyme. In particular, LDHC5 has been shown to have altered activity in muscle cells, which may make it a potential drug target or biomarker for muscle disease.

One of the key features of LDHC5 is its ability to interact with other proteins, particularly with the protein known asPDGF-BB. This protein is involved in cell signaling and has been shown to play a role in muscle growth and recovery. By interacting withPDGF-BB, LDHC5 may be able to regulate muscle cell growth and function, which could be useful for treating muscle-related diseases.

Another potential function of LDHC5 is its role in the metabolism of muscle protein synthesis. muscle protein synthesis is a critical process for muscle growth and recovery, and LDHC5 may be involved in this process by regulating the production of muscle protein.

LDHC5 has also been shown to be involved in the regulation of cellular signaling pathways that are important for muscle growth and recovery. For example, LDHC5 has been shown to be involved in the regulation of the signaling pathway known as the TGF-β pathway. This pathway is involved in the regulation of cell growth, differentiation, and survival, and is a key factor in muscle growth and recovery.

In addition to its potential role in muscle protein synthesis and cellular signaling pathways, LDHC5 may also be involved in the regulation of other processes in the body. For example, LDHC5 has been shown to be involved in the regulation of inflammation, which is important for many diseases, including muscle-related diseases.

Given its potential involvement in muscle protein synthesis, cellular signaling pathways, and inflammation, LDHC5 may be a promising drug target or biomarker for a variety of muscle-related diseases. For example, LDHC5 may be a potential target for muscle-related cancers, as it has been shown to be involved in the regulation of cell growth and survival. It may also be a potential target for muscle-related autoimmune diseases, as it has been shown to be involved in the regulation of immune cell function.

In addition to its potential clinical applications, LDHC5 may also be a valuable research tool for studying the role of gene function in muscle growth and recovery. By studying the genetic and molecular mechanisms underlying LDHC5's altered activity in muscle cells, researchers may be able to gain insights into the regulation of muscle growth and recovery, and may identify new targets for therapeutic intervention.

Overall, LDHC (Lactate Dehydrogenase C Variant 5) is a gene that has the potential to be a drug target or biomarker for a variety of muscle-related diseases. Its altered activity in muscle cells, as well as its involvement in cellular signaling pathways and the regulation of muscle protein synthesis, make it an attractive target for research and clinical intervention. Further research is needed to fully understand the role of LDHC5 in muscle growth and recovery, and to identify its potential as a therapeutic intervention.

Protein Name: Lactate Dehydrogenase C

Functions: Possible role in sperm motility

The "LDHC Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LDHC comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets